SD Biosensor, Inc. (KRX:137310)

South Korea · Delayed Price · Currency is KRW

6,130.00

-60.00 (-0.97%)

Last updated: Sep 2, 2026, 10:00 AM KST

SD Biosensor Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	738,760	710,581	694,574	655,677	2,932,001	2,929,961
Revenue Growth	5.15%	2.31%	5.93%	-77.64%	0.07%	73.77%
Gross Profit	341,000	321,449	336,971	122,449	1,390,110	1,593,176
Operating Income	-65,800	-82,853	-54,471	-248,085	1,146,624	1,387,733
Net Income	-729,491	-512,106	-98,411	-467,712	911,362	1,088,471
Earnings Per Share	-6094.00	-4279.19	-805.00	-4219.00	8996.76	11161.00
EPS Growth	-	-	-	-	-19.39%	69.54%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	449,515	774,175	467,750	557,717	2,069,971	1,895,499
Total Debt	289,120	673,040	610,862	608,476	30,694	195,668
Net Cash (Debt)	160,395	101,135	-143,112	-50,759	2,039,277	1,699,830
Net Cash Growth	-1.93%	-	-	-	19.97%	306.25%
Net Cash Per Share	1339.90	845.09	-1170.66	-457.86	20131.28	17430.38

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	56,743	357,516	156,527	-242,319	889,008	1,234,945
Capital Expenditures	-45,614	-57,086	-78,783	-142,566	-301,999	-190,053
Free Cash Flow	11,129	300,431	77,744	-384,884	587,008	1,044,892
Free Cash Flow Growth	-96.77%	286.44%	-	-	-43.82%	137.22%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	46.16%	45.24%	48.52%	18.68%	47.41%	54.37%
Operating Margin	-8.91%	-11.66%	-7.84%	-37.84%	39.11%	47.36%
Pretax Margin	-107.57%	-129.21%	-31.56%	-66.89%	42.36%	49.98%
Profit Margin	-98.75%	-72.07%	-14.17%	-71.33%	31.08%	37.15%
FCF Margin	1.51%	42.28%	11.19%	-58.70%	20.02%	35.66%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	-	3.37	5.27
Forward PE	-	13.43	13.43	13.43	4.73	5.53
P/FCF Ratio	66.53	3.54	16.18	-	5.24	5.49
PS Ratio	1.00	1.50	1.81	2.13	1.05	1.96